JPS5356684A - Improvement concerning organic compound - Google Patents

Improvement concerning organic compound

Info

Publication number
JPS5356684A
JPS5356684A JP11601777A JP11601777A JPS5356684A JP S5356684 A JPS5356684 A JP S5356684A JP 11601777 A JP11601777 A JP 11601777A JP 11601777 A JP11601777 A JP 11601777A JP S5356684 A JPS5356684 A JP S5356684A
Authority
JP
Japan
Prior art keywords
organic compound
improvement concerning
concerning organic
improvement
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11601777A
Other languages
Japanese (ja)
Inventor
Keraaayusuren Kamira
Kuun Matsukusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5356684A publication Critical patent/JPS5356684A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP11601777A 1976-09-28 1977-09-27 Improvement concerning organic compound Pending JPS5356684A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CH1224776 1976-09-28
CH1245076 1976-10-01
CH1244976 1976-10-01
CH1294276 1976-10-13
CH1294176 1976-10-13
CH1357476 1976-10-28
CH161577 1977-02-10
CH161677 1977-02-10
CH206077 1977-02-18

Publications (1)

Publication Number Publication Date
JPS5356684A true JPS5356684A (en) 1978-05-23

Family

ID=27575767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11601777A Pending JPS5356684A (en) 1976-09-28 1977-09-27 Improvement concerning organic compound

Country Status (7)

Country Link
JP (1) JPS5356684A (en)
AU (1) AU2912777A (en)
BE (1) BE859067A (en)
DE (1) DE2742435A1 (en)
FR (1) FR2365554A1 (en)
IL (1) IL53000A0 (en)
NL (1) NL7710418A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6425797A (en) * 1979-12-13 1989-01-27 Lilly Co Eli Cyclic peptide nucleus derivative

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU146480A (en) * 1979-06-08 1983-02-28 Lilly Co Eli Process for obtaining antibiotics
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4299763A (en) * 1979-12-13 1981-11-10 Eli Lilly And Company A-30912B Nucleus
US4293491A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4320054A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4322338A (en) * 1979-12-13 1982-03-30 Eli Lilly And Company Derivatives of A-30912B nucleus
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293490A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912H Nuclei
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
FR2476074A1 (en) * 1979-12-13 1981-08-21 Lilly Co Eli Acylated amino poly:cyclic peptide antibiotics - useful for controlling fungal infections
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4304716A (en) * 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4293483A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293487A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912D nucleus
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4299762A (en) * 1979-12-13 1981-11-10 Eli Lilly And Company A-30912D Nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5399552A (en) * 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
US5914313A (en) * 1991-10-17 1999-06-22 Merck & Co., Inc. 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5874403A (en) * 1992-10-15 1999-02-23 Merck & Co., Inc. Amino acid conjugates of cyclohexapeptidyl amines
AU5354094A (en) * 1992-10-16 1994-05-09 Merck & Co., Inc. An improved process for cyclohexapeptidyl bisamine compounds
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US6268338B1 (en) 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
WO1994025045A1 (en) * 1993-05-04 1994-11-10 Merck & Co., Inc. Cyclohexapeptidyl aminoalkyl ethers
WO1995008341A1 (en) * 1993-09-22 1995-03-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
DE69513408T2 (en) * 1994-08-23 2000-06-08 Merck & Co Inc AN IMPROVED METHOD FOR THE PRODUCTION OF SIDE CHAIN DERIVATIVES OF CYCLOHEXAPEPTIDYL LIPOPEPTIDES
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
CA2211138A1 (en) * 1995-01-26 1996-08-01 Merck & Co., Inc. Novel antifungal cyclohexapeptides
WO2016201283A1 (en) 2015-06-12 2016-12-15 Cidara Therapeutics, Inc. Antifungal agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704030A1 (en) * 1976-02-12 1977-08-18 Sandoz Ag NEW ORGANIC COMPOUNDS, THEIR PRODUCTION AND USE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6425797A (en) * 1979-12-13 1989-01-27 Lilly Co Eli Cyclic peptide nucleus derivative
JPH0353320B2 (en) * 1979-12-13 1991-08-14 Lilly Co Eli

Also Published As

Publication number Publication date
NL7710418A (en) 1978-03-30
DE2742435A1 (en) 1978-04-06
BE859067A (en) 1978-03-28
IL53000A0 (en) 1977-11-30
FR2365554A1 (en) 1978-04-21
AU2912777A (en) 1979-04-05

Similar Documents

Publication Publication Date Title
JPS5356684A (en) Improvement concerning organic compound
ZA7757B (en) Organic compounds
JPS5368786A (en) Heterocycltc compound
JPS52151348A (en) Compound
JPS5363424A (en) Bitumious compound
JPS52125197A (en) Transshexahydroopyridooindole compound
CY1261A (en) Organic compounds
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
JPS5295689A (en) Betaalactummcontaining compound
JPS5359686A (en) Compound
JPS55127390A (en) Aryltrifluoroethylamine compound
JPS5337653A (en) 111deoxyy111oxaprostaglandin compound
JPS5325537A (en) Compound
JPS52116496A (en) Improvement in organic compound
JPS52100478A (en) Improvement on organic compounds
JPS5293772A (en) Indolinospiropyran compound
ZA774756B (en) Organic compounds
JPS5323995A (en) Antiibacterial compound
AU2405177A (en) Organic compounds
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52156899A (en) Compound
JPS5344598A (en) Improvement concerning about organic compound
JPS5353692A (en) Antiiworm compound
JPS536416A (en) 55fluorouracli inclusion compound
JPS55102588A (en) Tetraselenapentalene compound